The new type of nonopioid painkiller from Vertex Pharmaceuticals is called Journavx, or suzetrigine, and was approved to treat moderate to severe acute, or short-term, pain in adults. Experts say ...

Two leading over-the-counter painkillers, ibuprofen and paracetemol, may increase the risk of high blood pressure, a study suggests. The Harvard research involved more than 80,000 American women ...

Want a say in the news? Email Claudia at [email protected] to have your thoughts on the stories covered here or on PennLive heard. Pennsylvanian doctors are weighing in on Journavx, a newly ...

Salt Lake County District Attorney Sim Gill has brought sexual assault charges against a former bishop of the Church of Jesus Christ of Latter-day Saints, according to a press release from the DA's ...

Used to treat inflammation, mild to moderate pain, and fevers. Usually taken orally, through the form of pills, powders, and liquids. Some well known pain killers are Ibuprofen, Advil, Tylenol, and ...

The FAA says the crew of Republic Airways Flight 4514 had to perform a "go-around" at Ronald Reagan Washington National Airport (DCA) around 8 p.m. Tuesday after learning a military helicopter was ...

The number of opioid prescriptions has since decreased, and the current wave of the opioid epidemic is driven mainly by illegal fentanyl rather than prescription painkillers. Opioids reduce pain ...

What's more, the new painkiller doesn't include opioids like many painkillers currently on the market do. The FDA announced Thursday (Jan. 30) that it had approved the new class of prescription ...

Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing ...

Vertex began researching the drug in the 2000s, when overdoses were rocketing upward, principally driven by mass prescribing of opioid painkillers for common ailments like arthritis and back pain.

Vertex began researching the drug in the 2000s, when overdoses were rocketing upward, principally driven by mass prescribing of opioid painkillers for common ailments like arthritis and back pain.

The Food and Drug Administration approved a new type of pain reliever for the first time in decades. It’s a new drug that could help combat America’s opioid crisis.